coronary artery disease
Conditions
Interventions
experimental:3-month-use of smart health monitoring devices
control group:Nil
Sponsors
Xiyuan Hospital, China Academy of Chinese Medical Sciences
Eligibility
Sex/Gender
All
Age
60 Years to 99 Years
Inclusion criteria
Inclusion criteria: (1) Age equals to or above 60, with no restriction on sex; (2) Patients with over 50% stenosis in single or multiple coronary arteries confirmed by coronary angiography or coronary computed tomography; or patients with a history of myocardial infarction; or patients who have undergone PCI/CABG and been stable for at least a month. (3) Patients who agree to participate and have signed an informed consent.
Exclusion criteria
Exclusion criteria: (1) Patients with serious mental diseases and impaired cognitive function,or patients in end stage of serious chronic disease with evident poor life expectancy of less than one year. (2) Patients who are likely to have a poor compliance and not reply to our follow-up survey. (3) Patients that are not suitable for the study as considered by researchers.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| cardiac death;non-fatal myocardial infarction;coronary artery revascularization;non-fatal stroke; | — |
Secondary
| Measure | Time frame |
|---|---|
| all-cause death;re-hospitalization due to unstable angina;newly-onset heart failure or re-hospitalization due to heart failure;newly-onset arrhythmia or re-hospitalization due to arrhythmia;newly-onset transient ischemia attack;other complications due to blood embolism; | — |
Countries
China
Contacts
Public ContactHao Xu
Beijing University of Chinese Medicine
Outcome results
None listed